Shopping Cart
Remove All
Your shopping cart is currently empty
PF-03715455 potently inhibits LPS-induced TNFα production in human whole blood (IC50=1.7 nM). PF-03715455 is an effective inhibitor of inhaled p38 MAPK. PF-03715455 displays some selectivity for p38α over p38β (respective IC50: 0.88 and 23 nM). PF-03715455 has the potential for the treatment of COPD.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $2,720 | 3-6 months | 3-6 months | |
| 50 mg | $3,580 | 3-6 months | 3-6 months | |
| 100 mg | $4,900 | 3-6 months | 3-6 months |
| Description | PF-03715455 potently inhibits LPS-induced TNFα production in human whole blood (IC50=1.7 nM). PF-03715455 is an effective inhibitor of inhaled p38 MAPK. PF-03715455 displays some selectivity for p38α over p38β (respective IC50: 0.88 and 23 nM). PF-03715455 has the potential for the treatment of COPD. |
| Targets&IC50 | p38β:23 nM, p38α:0.88 nM |
| In vitro | PF-03715455 is a moderate inhibitor of CYP1A2, CYP2C19, and CYP2D6, and a potent inhibitor of CYP2C9 and CYP3A4[2]. |
| In vivo | PF-03715455 treatment displays that the Vss is 0.19 L/kg and T1/2 is 1 hour [2]. |
| Molecular Weight | 700.27 |
| Formula | C35H34ClN7O3S2 |
| Cas No. | 1056164-52-3 |
| Smiles | S(C1=CN2C(=NN=C2C=C1)C3=C(SCCO)C=CC=C3)C4=C(CNC(NC=5N(N=C(C(C)(C)C)C5)C6=CC(Cl)=C(O)C=C6)=O)C=CC=C4 |
| Relative Density. | 1.39 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.